Seekyo

Developer of selective cancer drug delivery systems

placePoitiers, Nouvelle Aquitaine, France calendar_todayFounded 2018 groups9 employees language seekyo-therapeutics.com

Social engagement

Social engagement: 1.5K social following, 8 posts in the last 12 months — above the industry median.

Investor mix

6 investors on record; lead investors include Bpifrance, Synergence, Investessor.

Investor typeCountShare
Venture capital117%
Private equity117%
Angel & family office117%
Accelerator & incubator117%
Bank & private debt117%
Other / undisclosed117%

Recent activity

18 Jun 2026
Product launch
SKY01
15 Jun 2026
Product launch
SKY01 / Tumor Activated TherapyTM
20 Apr 2026
Event
BioEquity Europe 2026
Coming soon